JP2017516838A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017516838A5 JP2017516838A5 JP2016575290A JP2016575290A JP2017516838A5 JP 2017516838 A5 JP2017516838 A5 JP 2017516838A5 JP 2016575290 A JP2016575290 A JP 2016575290A JP 2016575290 A JP2016575290 A JP 2016575290A JP 2017516838 A5 JP2017516838 A5 JP 2017516838A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- salt
- formula
- composition
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 26
- 150000003839 salts Chemical class 0.000 claims 17
- 238000000034 method Methods 0.000 claims 9
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims 4
- 239000012620 biological material Substances 0.000 claims 3
- 229920001184 polypeptide Polymers 0.000 claims 3
- 102000004196 processed proteins & peptides Human genes 0.000 claims 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims 3
- 102000004506 Blood Proteins Human genes 0.000 claims 2
- 108010017384 Blood Proteins Proteins 0.000 claims 2
- 108090000790 Enzymes Proteins 0.000 claims 2
- 102000004190 Enzymes Human genes 0.000 claims 2
- 102000004877 Insulin Human genes 0.000 claims 2
- 108090001061 Insulin Proteins 0.000 claims 2
- 102000013460 Malate Dehydrogenase Human genes 0.000 claims 2
- 108010026217 Malate Dehydrogenase Proteins 0.000 claims 2
- 108010059724 Micrococcal Nuclease Proteins 0.000 claims 2
- 102000016943 Muramidase Human genes 0.000 claims 2
- 108010014251 Muramidase Proteins 0.000 claims 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims 2
- -1 antibody Proteins 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 2
- 229940088598 enzyme Drugs 0.000 claims 2
- 229940088597 hormone Drugs 0.000 claims 2
- 239000005556 hormone Substances 0.000 claims 2
- 229940125396 insulin Drugs 0.000 claims 2
- 229960000274 lysozyme Drugs 0.000 claims 2
- 235000010335 lysozyme Nutrition 0.000 claims 2
- 239000004325 lysozyme Substances 0.000 claims 2
- 239000000126 substance Substances 0.000 claims 2
- 238000001035 drying Methods 0.000 claims 1
- 230000000087 stabilizing effect Effects 0.000 claims 1
- 0 *C(C(*)OC(CO)C1O)C1O Chemical compound *C(C(*)OC(CO)C1O)C1O 0.000 description 6
- IBCLFTZLTSNOCK-FIZLLRJRSA-N CC(CC(O)=O)O[C@H](C1C2O)O[O]1C(CN)[C@H]2O Chemical compound CC(CC(O)=O)O[C@H](C1C2O)O[O]1C(CN)[C@H]2O IBCLFTZLTSNOCK-FIZLLRJRSA-N 0.000 description 1
- RKJBLGRZNLZBHK-RXMQYKEDSA-N CC[O]([C@H](CN)O)=C Chemical compound CC[O]([C@H](CN)O)=C RKJBLGRZNLZBHK-RXMQYKEDSA-N 0.000 description 1
- LTQIONUUDMTTOJ-NPYQJARQSA-N NC(C1O)[C@@H](O[C@@H](CO)C(O)=O)OC(CO)[C@H]1O Chemical compound NC(C1O)[C@@H](O[C@@H](CO)C(O)=O)OC(CO)[C@H]1O LTQIONUUDMTTOJ-NPYQJARQSA-N 0.000 description 1
- DOGRTOSKFWKTKZ-BJULKVSLSA-N OCC([C@H](C(C12)O)O)[O]1O[C@@H]2O[C@@H](CC(O)=O)C(O)=O Chemical compound OCC([C@H](C(C12)O)O)[O]1O[C@@H]2O[C@@H](CC(O)=O)C(O)=O DOGRTOSKFWKTKZ-BJULKVSLSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461953392P | 2014-03-14 | 2014-03-14 | |
| US61/953,392 | 2014-03-14 | ||
| PCT/PT2015/050001 WO2015137838A1 (en) | 2014-03-14 | 2015-03-13 | Hexose derivatives, preparation and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020097767A Division JP7077361B2 (ja) | 2014-03-14 | 2020-06-04 | ヘキソース誘導体、その製剤および使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017516838A JP2017516838A (ja) | 2017-06-22 |
| JP2017516838A5 true JP2017516838A5 (https=) | 2018-04-26 |
| JP7067867B2 JP7067867B2 (ja) | 2022-05-16 |
Family
ID=53264710
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016575290A Active JP7067867B2 (ja) | 2014-03-14 | 2015-03-13 | ヘキソース誘導体、その製剤および使用 |
| JP2020097767A Active JP7077361B2 (ja) | 2014-03-14 | 2020-06-04 | ヘキソース誘導体、その製剤および使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020097767A Active JP7077361B2 (ja) | 2014-03-14 | 2020-06-04 | ヘキソース誘導体、その製剤および使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11708387B2 (https=) |
| EP (1) | EP3116886A1 (https=) |
| JP (2) | JP7067867B2 (https=) |
| KR (3) | KR102651029B1 (https=) |
| CN (2) | CN106573952A (https=) |
| BR (1) | BR112016021231B1 (https=) |
| CA (1) | CA2942635C (https=) |
| IL (1) | IL247531B (https=) |
| MX (1) | MX386787B (https=) |
| RU (1) | RU2731563C2 (https=) |
| SG (2) | SG10201807891UA (https=) |
| WO (1) | WO2015137838A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102651029B1 (ko) * | 2014-03-14 | 2024-03-25 | 파쿠우다지 지 씨엔씨아스 다 우니베르시다지 지 리스보아 | 헥소스 유도체, 그의 제제 및 용도 |
| FR3061013B1 (fr) * | 2016-12-22 | 2020-04-17 | Greenpharma | Composition contenant le digeneaside, son procede d'obtention et son utilisation cosmetique, veterinaire ou nutraceutique |
| US12098162B2 (en) * | 2017-11-13 | 2024-09-24 | Extremochem, Lda | Neutral glycosylated amides and dianionic glucuronidated acids as stabilizers for biological molecules |
| CN116251110B (zh) * | 2022-11-18 | 2025-02-14 | 广东药科大学 | β-D-吡喃葡萄糖基-乳酸及其衍生物在制备治疗代谢性疾病、炎症药物中的应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060099567A1 (en) * | 2004-04-08 | 2006-05-11 | Biomatrica, Inc. | Integration of sample storage and sample management for life science |
| DE102004031588A1 (de) * | 2004-06-30 | 2006-02-09 | Symrise Gmbh & Co. Kg | Verwendung von Äpfelsäureglucosiden als Geschmacksstoffe |
| PT103442A (pt) * | 2006-02-24 | 2007-08-31 | Stab Vida Investigacao E Servi | Derivados sintéticos de manosil-glicerato para a estabilização e/ou preservação de biomateriais |
| PT103441A (pt) | 2006-02-24 | 2007-08-24 | Stab Vida Investigacao E Servi | Utilização de solutos compatíveis para melhorar o desempenho de técnicas utilizando materiais biológicos imobilizados |
| DE102010038496A1 (de) | 2010-07-27 | 2012-02-02 | Henkel Ag & Co. Kgaa | Stabilisierte flüssige enzymhaltige Tensidzubereitung |
| DE102011118027A1 (de) * | 2011-09-12 | 2013-03-14 | Henkel Ag & Co. Kgaa | Verfahren zur Anpassung eines Hydrolytischen Enzyms an eine das hydrolytische Enzym stabilisierende Komponente |
| KR102651029B1 (ko) | 2014-03-14 | 2024-03-25 | 파쿠우다지 지 씨엔씨아스 다 우니베르시다지 지 리스보아 | 헥소스 유도체, 그의 제제 및 용도 |
| JP2020097767A (ja) | 2018-12-18 | 2020-06-25 | 株式会社東芝 | 表面処理剤、これを用いた積層体、及び無電解めっき製品 |
-
2015
- 2015-03-13 KR KR1020227017066A patent/KR102651029B1/ko active Active
- 2015-03-13 JP JP2016575290A patent/JP7067867B2/ja active Active
- 2015-03-13 KR KR1020247009385A patent/KR102828884B1/ko active Active
- 2015-03-13 US US15/125,522 patent/US11708387B2/en active Active
- 2015-03-13 BR BR112016021231-2A patent/BR112016021231B1/pt active IP Right Grant
- 2015-03-13 KR KR1020167028609A patent/KR102401853B1/ko active Active
- 2015-03-13 SG SG10201807891UA patent/SG10201807891UA/en unknown
- 2015-03-13 MX MX2016011808A patent/MX386787B/es unknown
- 2015-03-13 CA CA2942635A patent/CA2942635C/en active Active
- 2015-03-13 CN CN201580014386.4A patent/CN106573952A/zh active Pending
- 2015-03-13 EP EP15724386.6A patent/EP3116886A1/en active Pending
- 2015-03-13 RU RU2016140337A patent/RU2731563C2/ru active
- 2015-03-13 CN CN202211044372.5A patent/CN115448964A/zh active Pending
- 2015-03-13 WO PCT/PT2015/050001 patent/WO2015137838A1/en not_active Ceased
- 2015-03-13 SG SG11201607530XA patent/SG11201607530XA/en unknown
-
2016
- 2016-08-29 IL IL247531A patent/IL247531B/en active IP Right Grant
-
2020
- 2020-06-04 JP JP2020097767A patent/JP7077361B2/ja active Active
-
2023
- 2023-06-09 US US18/332,157 patent/US12590117B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017516838A5 (https=) | ||
| JP2014000092A5 (https=) | ||
| EA033396B1 (ru) | Быстродействующие инсулиновые композиции | |
| JP2012184234A5 (https=) | ||
| CL2014003637A1 (es) | Anticuerpo monoclonal optimizado que se une al gen 3 de activación de linfocitos (lag-3); molécula biespecífica que lo comprende; inmunoconjugado que comprende el anticuerpo unido a un agente terapéutico; composición; ácido nucleico; vector; célula huésped; método de preparación; y uso para inhibir el crecimiento de un tumor o tratar una infección viral. | |
| JP2016505044A5 (https=) | ||
| JP2016040288A5 (https=) | ||
| JP2016520647A5 (https=) | ||
| HRP20250541T1 (hr) | Isporuka mikro-distrofina s adeno-povezanim virusnim vektorom za liječenje mišićne distrofije | |
| JP2016521119A5 (https=) | ||
| JP2012512907A5 (https=) | ||
| EP4632075A3 (en) | Method for reducing immunogenicity of rna | |
| JP2016512425A5 (https=) | ||
| UA117103C2 (uk) | Сполука, яка має активність агоніста глюкагону | |
| PH12018500690A1 (en) | Novel insulin analogs and use thereof | |
| JP2016515561A5 (https=) | ||
| NZ739902A (en) | Multiligand agent for drug delivery | |
| JP2014520852A5 (https=) | ||
| JP2017514868A5 (https=) | ||
| JP2017514910A5 (https=) | ||
| JP2013518815A5 (https=) | ||
| JP2019525899A5 (https=) | ||
| BR112022008750A2 (pt) | Composto de ligação de receptor duplo, composição farmacêutica, método para tratar uma doença em um paciente, método para expandir células imunes, método para reforçar uma vacina, método para modificar a resposta imune e ácido nucleico | |
| RU2019118696A (ru) | Фармацевтические композиции, содержащие инсулин | |
| JP2019516739A5 (https=) |